Ascendis Pharma A/S (ASND)

Ascendis Pharma Revenue

Ascendis Pharma had revenue of 158.05M EUR in the quarter ending June 30, 2025, with 339.04% growth. This brings the company's revenue in the last twelve months to 490.75M, up 54.50% year-over-year. In the year 2024, Ascendis Pharma had annual revenue of 363.64M with 36.34% growth.

• Revenue (ttm): 490.75M EUR
• Revenue Growth: +54.50%
• P/S Ratio: 22.16
• Revenue / Employee: 482,544 EUR
• Employees: 1,017
• Market Cap: 13.12B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	363.64M	96.92M	36.34%
Dec 31, 2023	266.72M	215.54M	421.20%
Jan 1, 2023	51.17M	43.40M	557.93%
Dec 31, 2021	7.78M	825.00K	11.87%
Dec 31, 2020	6.95M	-6.42M	-48.01%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.